Trial intelligence / Profile preview

Tacrolimus vs Fluticasone in Pediatric Atopic Dermatitis

NCT00689832Phase 4Completed

Sponsor
Astellas Pharma
Start
Feb 2004
Primary completion
Aug 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Tacrolimus Ointment 0.1% Iwaki in atopic dermatitis (AD), sponsored by Astellas Pharma. Started Feb 2004; status: completed.

02

Drugs

Tacrolimus Ointment 0.1% Iwaki
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT00689832.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00689832.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call